Corporate overviewAterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its unique understanding of atherosclerosis. |
ProductsOur first diagnostic product, AteroDx Activity®, is now available. The test detects the activity of the sPLA2 enzyme family, which has been validated as a potent biomarker of the vulnerable or destabilised atherosclerotic plaque. |
Scientific evidencesPLA2 is a powerful cardiovascular biomarker which has been evaluated through many clinical studies, including 10,000 patients. A bibliography is available here.
|